Our passion for the work we do is matched only by our commitment to consistently provide the best customer experience possible.
AliveDx recently partnered with the Great Place To Work organization to support our journey toward becoming an exceptional workplace for all our employees. Our goal is to foster a sense of belonging, instill pride in the work we do, and
We are excited to announce that two AliveDx abstracts are now available publicly in the Abstract Book of the European Congress of Rheumatology (EULAR 2024), an international event that will take place in Vienna, Austria from 12-15 June 2024. The
We are pleased to announce that our Eysins site in Switzerland has successfully passed the annual ISO 14001 Surveillance Audit. This site, first certified in 2022, continues to demonstrate our commitment to environmental management and sustainability. The ISO 14001 is
AliveDx Suisse S.A. and Palex Medical S.A.U. have signed a distribution agreement, which will enable Palex to distribute the MosaiQ® solution in Spain. The distribution agreement takes effect immediately. This partnership reaffirms AliveDx’s commitment to expanding its geographical presence and
AliveDx Suisse S.A. and Medical Development Medical Devices WLL have signed a distribution agreement, which will enable Medical Development Medical Devices to distribute the MosaiQ® solution in the Kingdom of Bahrain. The distribution agreement takes effect immediately. AliveDx is dedicated
AliveDx Suisse S.A. and Lavichem Joint Stock Company have signed a distribution agreement, which will enable Lavichem to distribute the MosaiQ® solution in North Vietnam. The distribution agreement takes effect immediately. AliveDx is committed to broadening its reach and presence